Interdisciplinary treatment of glioblastoma: analysis of prognostic factors and treatment results in unselected patients.

Neoplasma

Volumn 59, Issue 6, 2012, Pages 662-668

  Langsenlehner, T ^a   Groll, M J ^b   Quehenberger, F ^b   Payer, F ^b   Mokry, M ^b   Kapp, K S ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE;

EID: 84872680987     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2012_084     Document Type: Article

References (0)